Neutrophil-mediated and low density lipoprotein receptor-mediated dual-targeting nanoformulation enhances brain accumulation of scutellarin and exerts neuroprotective effects against ischemic stroke.

导出 OA

翻译打印收藏纠错

第一作者： Yanxin,Dang

第一单位： Department of Pharmaceutical Engineering, School of Chemical and Environmental Engineering, Key Laboratory of Green Chemical Engineering, Harbin University of Science and Technology Harbin China xinliu98@126.com xin.liu@yale.edu sunxiaojun361@163.com.

作者： Yanxin,Dang ^[1] ; Chiying,An ^[2] ; Yutao,Li ^[3] ; Dandan,Han ^[1] ; Xin,Liu ^[1] ; Fengming,Zhang ^[1] ; Yuan,Xu ^[4] ; Haijing,Zhong ^[1] ; Mewand Khan,Karim Khan ^[4] ; Fengjuan,Zou ^[4] ; Xiaojun,Sun ^[2]

作者单位： Department of Pharmaceutical Engineering, School of Chemical and Environmental Engineering, Key Laboratory of Green Chemical Engineering, Harbin University of Science and Technology Harbin China xinliu98@126.com xin.liu@yale.edu sunxiaojun361@163.com. ^[1] Heilongjiang Province Rehabilitation Hospital Harbin China. ^[2] The First Affliated Hospital of Harbin Medical University Harbin China. ^[3] Department of Pharmacology, School of Medicine, Yale University New Haven Connecticut USA. ^[4]

DOI 10.1039/c8ra06688d

PMID 35518053

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

RSC advances

2019年9卷3期

1299-1318页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Neutrophil-mediated and low density lipoprotein receptor-mediated dual-targeting nanoformulation enhances brain accumulation of scutellarin and exerts neuroprotective effects against ischemic stroke.

RSC advances

相似文献

RSC advances

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Neutrophil-mediated and low density lipoprotein receptor-mediated dual-targeting nanoformulation enhances brain accumulation of scutellarin and exerts neuroprotective effects against ischemic stroke.

RSC advances

相似文献

RSC advances

相关期刊

检索历史清除